Rezultaty - Daniel Sentana‐Lledo
- Rezultaty 1 - 1 Rezultaty od 1
-
1
EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates od Daniel Sentana‐Lledo, Emmeline C. Academia, Hollis Viray, Deepa Rangachari, Susumu Kobayashi, Paul A. VanderLaan, Daniel B. Costa
Wydane 2023Revisão